ArticleFrontiers in endocrinology2022

Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma.

Wei-Ming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.